Cipla’s generic Viread approved by the FDA
The Food and Drug Administration has approved Cipla’s generic Viread (tenofovir disoproxil fumarate) tablets. Cipla said it would begin shipping the drug immediately.
The drug is indicated to treat patients ages 12 years and older with HIV-1 in combination with other antiretroviral agents. Cipla’s generic Viread will be available in 300-mg dosage strength. The product had U.S. sales of roughly $725 million for the 12 months ended November 2017, according to IQVIA data.
Perrigo’s generic Onexton Gel gets tentative FDA nod
The Food and Drug Administration has tentatively approved Perrigo’s generic Onexton Gel (clindamycin phosphate 1.2% and benzoyl peroxide 3.75%). Perrigo said that it had previously settled litigation with Valeant Pharmaceuticals North America and Dow Pharmaceutical Sciences for the product.
“This tentative approval is another example of making long-term investments in our extended topicals strategy,” Perrigo executive vice president and president Rx pharmaceuticals John Wesolowski said. “The Rx team continues to invest in bringing important products to market that provide savings to patients and healthcare systems.”
Onexton Gel is indicated to treat acne vulgaris in patients ages 12 years and older. The product had branded sales of $115 million for the past 12 months, Perrigo said.
Publix, BayCare Health System launch telehealth center
Publix and BayCare Health System have joined forces in creating Walk-In Care by BayCare. This telehealth service will contain a private room where patients can receive non-urgent medical care from physicians through teleconferencing and diagnostic equipment.
The interactive kiosk allows patients to enter their symptoms and work with medical tools, such as thermometers, otoscopes, blood pressure cuffs and high definition cameras to make an accurate diagnosis. Publix Pharmacy staff also will be on hand to provide patients with additional assistance if needed.
“We are excited to bring access to high-quality, compassionate care through this convenient and innovative technology,” Glenn Waters, executive vice president and chief operating officer at BayCare Health System, said. “Our goal is to improve the health of our community by helping individuals access the right level of care in the right place. Our collaboration with Publix helps us do just that.”
The first center opened in December 2017 at Publix Shoppes of Lithia in Florida, and 26 additional locations are to be added by the end of the year. Walk-In Care Provided by BayCare is part of a three-part collaboration between both companies to improve the overall health and wellness of the Tampa community.
“Pharmacists are a part of many patients’ wellness plans, and our Publix Pharmacists have been serving our communities through a variety of services like vaccinations, health screenings, free and discounted medications, and more,” Maria Brous, Publix director of media and community relations, said. “This Walk-In Care clinic takes our partnership with physicians to a new level. Together, we’ll help keep our community feeling well.”